Dia-B Tech Ltd. Happy with Phase 2 Diabetes Drug Published: Dec 06, 2007 Diabetes development firm Dia-B Tech Ltd intends to move to Phase II trials of its drug ISF402 for the treatment of type 2 diabetes, after receiving "encouraging" results for the Phase I trial. Related links Sydney Morning Herald This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news